Department of Internal Medicine

Endocrine-Metabolism Faculty

Thomas O'Dorisio, M.D.
Professor

Dr. O'Dorisio's research interests include sporadic and familial neuroendocrine tumors (e.g. carcinoid), diabetes mellitus - type 1 and type 2, and Thyroid disorders.

Honors, Awards, and Organizations

Teaching Award (Pre-Clinical), Class of ’92; Teaching Award (Clinical and Preclinical), Class of ’83
1995 OMEN-TV 3 Year Award of Appreciation, The Ohio State University
1995 Faculty Teaching Award, from Alumni Classes
Recipient of Donald V. Unverferth Faculty Achievement Award, Department of Internal medicine, June 1992
Outstanding Medical Student Research Advisor (Landacre Society, April 14, 1996)
The Best Doctors in America, Midwest Region (Woodward/White Inc.,Publisher), 1996-2002
"Top Doctors," Columbus Monthly, August 1998
Clinical Attending and Member, Holden Comprehensive Cancer Center, 2000-Present
Member of the American Society of Cancer Research

Thomas O'Dorisio photo

Medical School:
Creighton University

Residency:
Ohio State University

Fellowship:
Ohio State University

Patents

In vivo, in situ application of peptide/cell receptor kinetics utilizing radio-labelled somatostatin analogue, 204-090 and similar tyrosinated somatostatin/peptide analogues. (Principle Inventor: T.M. O’Dorisio, M.D., M. Sue O’Dorisio, M.D., Ph.D., E.. W. Martin, M.D., E.A. Woltering, M.D., joint inventors). Issued January 1997; #5,590,656.
Multi-Tyrosinated Somatostatin Analogs. (Principle Inventor: Dr. D.H. Coy; Drs. W.A. Murphy, E.A. Woltering, M.S. O’Dorisio and T.M. O’Dorisio, joint inventors). Issued January 1997; #5,597,894.

Recent Publications

Madsen M, Bushnell D, Menda Y, Juweid M, O’Dorisio TM, O’Dorisio MS. Potential increased tumor dose delivery with combined 131I-MIBG and 90Y-DOTATOC treatment in neuroendocrine tumors: A theoretical model. Journal of Nuclear Medicine 2006, in press.
O’Dorisio TM, Kvols L. Safety and efficacy of pasireotide (SOM230) in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR: Results of a Phase II study. ASCO GI Cancers Symposium Poster Presentation, San Francisco CA, January 26-28, 2006.
Warner RR, O’Dorisio TM. Radiolabeled peptides in diagnosis and tumor imaging: Clinical overview. Semin Nucl Med 2002, 32(2):79-83.

PubMed publications list

Back to Endocrine-Metabolism Faculty List